TMK ADS (TMKXY) Financials Nov 14, 2014, 8:10 p.m.
Income
TMK ADS (TMKXY) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for TMK ADS
Fiscal year is January-December. All values RUB millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 109.86B 169.49B 198.56B 207.8B 204.98B
Cost of Goods Sold (COGS) incl. D&A 3.03B 4.38B 5.34B 5.27B 5.13B
COGS excluding D&A 2.71B 4.07B 5B 153.58B 4.81B
Depreciation & Amortization Expense 313.09M 312.86M 337.35M 10.13B 325.89M
Depreciation 205.29M - - 8.28B 276.79M
Amortization of Intangibles 107.8M - - 1.85B 49.1M
Gross Income 13.84B 36.42B 41.7B 44.09B 41.36B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 414.87M 564.92M 636.15M 683.38M 661.74M
Research & Development 9.68M 12.67M 17.69M 495.84M 12.52M
Other SG&A 12.86B 16.78B 18.18B 20.74B 20.69B
Other Operating Expense 730.16M 1.06B 3.2B 1.89B 1.48B
Unusual Expense 47.33M 12.36M (113.01M) 15.84M (3.05M)
EBIT after Unusual Expense (47.33M) (12.36M) 113.01M (15.84M) 3.05M
Non Operating Income/Expense 65.58M 26.23M 57.43M 983.67M (32.43M)
Non-Operating Interest Income 2.35M 3.02M 3.33M 208.8M 4.18M
Equity in Affiliates (Pretax) - 0 - - -
Interest Expense 446.88M 430.59M 302.79M 297.1M 252.25M
Gross Interest Expense 446.88M 430.59M 302.79M 9.33B 269.22M
Interest Capitalized 0 0 0 101.73M 16.97M
Pretax Income (13.59B) 5.63B 16B 12.43B 9.95B
Income Tax (3.27B) 2.47B 4.69B 3.81B 3.12B
Income Tax - Current Domestic (18.38M) 49.86M 97.4M 3.16B 80.37M
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic (84.64M) 31.32M 62.04M 655.4M 17.48M
Income Tax - Deferred Foreign - - - - -
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 44.95M 0 (5.44M) 1.27M 5.61M
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (10.28B) 3.16B 11.31B 8.62B 6.84B
Minority Interest Expense (254.54M) (7.9M) 134.28M 153.25M 19.47M
Net Income (315.73M) 104.33M 380.13M 272.59M 213.93M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (315.73M) 104.33M 380.13M 272.59M 213.93M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (315.73M) 104.33M 380.13M 272.59M 213.93M
EPS (Basic) (11.42) 3.65 12.94 9.94 7.97
Basic Shares Outstanding 866.62M 860.48M 864.98M 863.31M 865.03M
EPS (Diluted) (0.36) 0.12 0.40 0.32 0.25
Diluted Shares Outstanding 866.62M 860.48M 936.75M 863.31M 865.03M
EBITDA 311.19M 911.8M 1.01B 1B 915.53M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Collaboration to Captivate Art and Rock Enthusiasts When it comes to mixing rock and roll with fine art, Markus Klinko's exclusive photograph featuring the Hollywood Vampires hits the nail on the head. It’s not just an image; it’s a slice of modern rock history immortalized on paper. This new release, a portrait capturing the raw passion of Alice Cooper, Johnny...
Continue Reading
Boardwalk's Leadership Shift: Enter Scott Wexler Nothing spices up a pipeline company's menu like a fresh plate of leadership. Boardwalk Pipelines, out in Houston, just handed the keys to their finance dungeon over to Scott Wexler. He's stepping in as the chief financial officer and senior VP of corporate strategic development, an upgrade that got announced today. Packing...
Continue Reading
Deadline Extended for Kenvue's Noteholders In the wild world of corporate finance, the only thing more unpredictable than the weather is a boardroom decision. Kimberly-Clark (NASDAQ: KMB) just threw one such curveball by extending the deadline on their exchange offers for Kenvue Notes to November 2, 2026. Seems like 5 p.m. New York time is the new witching hour for this...
Continue Reading
The Evolving World of Agrochemicals You know, the agrochemical market isn't just about fertilizers and pesticides anymore. It's evolving into a high-stakes game of innovation, resistance management, and cutting-edge tech. This whole sector's forecast to explode to a whopping US$ 387.7 billion by 2031. That's no small potatoes. Driving Forces: Pests, Drones, and Regulatory...
Continue Reading
A Groundbreaking Partnership in Singapore's Healthcare Sector Every so often, something big comes along that makes you stop and take notice. This time, it's the alliance between the Infocomm Media Development Authority (IMDA) and the National University Hospital (NUH) in Singapore. By launching an Open Innovation Platform (OIP) partnership, they've embarked on a journey...
Continue Reading
O-Cyte 1 Leads the Charge at MEDICA 2026 With all the chatter floating around the latest whiz-bang healthcare technology, it's downright refreshing to stumble upon something as genuinely promising as Ozelle's O-Cyte 1. Slated to be the talk of the town at this year’s MEDICA in DÜSSELDORF, this shiny new automated hematology analyzer promises to marry the best of AI and...
Continue Reading
Compliance in a Changing Tech Landscape JumpCloud's stepping up in this brave new world riddled with tech and AI agents. They've got fresh platform features in their arsenal that'll keep organizations audit-ready day in and day out. Now, if you think compliance is just for the accountants to fret over, think again. In the agentic era, these advanced marvels—AI agents...
Continue Reading
Shifting Gears at Ameritas: New VP Takes the Helm Well, chalk one up for Ameritas on this move. They've just brought on Ying Zhao as the new vice president of actuarial and financial strategy. It's a mouthful of a title, sure, but it's the role itself that's worth watching. Ameritas, for those not tracking, is a major player in the insurance and financial universe, doing...
Continue Reading
Pouring Old Favorites: The Tiramisu Return When the aromas of coffee and nostalgia waft through the air, it's often a sign that The Coffee Bean & Tea Leaf® is brewing something special. This year, they've decided to double down on the holiday cheer by reintroducing their wildly popular Tiramisu beverage. This ain't just your run-of-the-mill coffee drink—it's a full-on...
Continue Reading
The Challenge of Moving AI to Production Diving headfirst into AI in finance? Well, Jacobi's bold move with their new toy, the Investment Management Harness, spotlights a filthy secret: the hurdles between a big idea and execution are seldom technological. We got AI shaving prototyping time down to just days, yet pushing to production? That's a marathon in itself. Boards...
Continue Reading
Top 5 Most Recently Viewed Articles
Market Overview: Global Insights The global financial landscape is constantly changing, and recent trends reveal interesting shifts in both Asian and European markets. As we explore these developments, we'll also take a look at how various sectors and commodities are performing, providing a comprehensive overview of current market conditions. U.S. Markets Performance On a...
Continue Reading
Attention XPLR Infrastructure, LP Investors The Gross Law Firm is reaching out to shareholders of XPLR Infrastructure, LP, formerly known as Nextera Energy Partners, LP (NYSE: XIFR). If you purchased shares during the designated class period, it's crucial to be aware of your rights and potential participation in an upcoming class action lawsuit. Understanding the Class...
Continue Reading
180 Life Sciences Corp. Prepares for Shareholders Meeting 180 Life Sciences Corp. (NASDAQ:ATNF), a pioneering name in the pharmaceutical field, is on track for its upcoming Annual Meeting of Shareholders. This significant event is earmarked for a future date while offering essential insights for those engaged with the company. Important Dates for Shareholders The Board of...
Continue Reading
Investor Alert for iRobot Corporation Attention all investors: If you’ve faced losses from your investments in iRobot Corporation (NASDAQ: IRBT), it’s crucial to pay attention to recent developments surrounding a significant class action lawsuit. This lawsuit, which involves allegations of securities fraud, may offer a pathway for recovery of your losses. What Is the...
Continue Reading
Overview of the Dental Bone Graft Substitute Market The dental bone graft substitute market is experiencing impressive growth. This increase is primarily attributed to the rise in dental health issues, the escalation of dental procedures, and the heightened interest in cosmetic dentistry. Recent market predictions suggest this segment could reach USD 1,098.48 million by...
Continue Reading